(IN BRIEF) The University of Glasgow is leading the PHOENIX Study, a landmark clinical trial investigating how genetic testing can personalise prescribing across NHS Scotland. Over 4,000 patients will be recruited across Greater Glasgow and Clyde to explore how DNA … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Technology, United Kingdom
Tagged adverse drug reactions, Agena Bioscience, DNA testing, genetic testing, Katriona Brooksbank, Living Laboratory, medication safety, MyDNA, NHS Greater Glasgow and Clyde, NHS prescribing, personalised medicine, PGx, pharmacogenomics, PHOENIX Study, precision healthcare, Queen Elizabeth University Hospital, Sandosh Padmanabhan, University of Glasgow, West of Scotland Innovation Hub
(IN BRIEF) From its leadership of key work packages to its rich data resources—the ESC Atlas of Cardiology and GRASP study—the European Society of Cardiology is driving EuroHeartPath’s mission to transform heart-disease care in Europe. This €27 million Horizon Europe … Read the full press release
Posted in Artificial Intelligence (AI), European Union, France, Healthcare, Netherlands, Society, Technology
Tagged AI machine learning, cardiovascular care pathways, data harmonization, digital health, dissemination, ESC Atlas of Cardiology, EuroHeartPath, European Society of Cardiology, EXPLAIN, GRASP program, Health Equity, Horizon Europe, IHI-JU, PACEVALUE, pathfinder studies, patient-centred care, point-of-care testing, policy recommendations, robotics, WP2, WP3, WP4, WP6, WP8, WP9
(IN BRIEF) The EIB is extending €235 million in loans to enhance public services in Finland’s Uusimaa region: €135 million for upgrading three major hospitals under Helsinki University Hospital’s broader €300 million program, and €100 million for building and refurbishing … Read the full press release
Posted in Banks, Education, European Union, Financial, Finland, Healthcare, Investment
Tagged educational facilities, EIB, energy efficiency, European Investment Bank, Finland investments, healthcare modernization, Helsinki University Hospital, HUS, Jari Finnilä, Jorvi Hospital, Meilahti Hospital, Peijas Hospital, Pekka Timonen, public services, sustainable infrastructure, Thomas Östros, Uusimaa, Vantaa schools
(IN BRIEF) BioNTech agreed to buy CureVac in an all-stock deal valuing CureVac at ~$1.25 billion, exchanging each share for $5.46 in BioNTech ADSs—a 55% premium to its recent stock price. The merger, expected to close in 2025, strengthens BioNTech’s … Read the full press release
Posted in Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged 2025 closing, ADSs, Alexander Zehnder, all-stock acquisition, American depositary shares, BioNTech, BNT327, Cancer Immunotherapy, CureVac, delivery formulations, dievini Hopp BioTech, integration plan, KfW, merger premium, mRNA, mRNA manufacturing, oncology strategy, pan-tumor programs, partnership, regulatory approvals, transformational therapies, Tübingen subsidiary, Ugur Sahin
(IN BRIEF) Boehringer Ingelheim and Eko Health have partnered to launch a canine-specific heart murmur detection solution in 2026. Leveraging Boehringer’s veterinary cardiology insights and proprietary algorithm alongside Eko’s AI-enabled digital stethoscopes and mobile app, the tool will help veterinarians … Read the full press release
Posted in Artificial Intelligence (AI), Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged AI algorithm, Boehringer Ingelheim, canine cardiology, Connor Landgraf, digital stethoscope, Dr. Erich Schött, early diagnosis, Eko Health, heart murmur detection, MMVD, mobile app, myxomatous mitral valve disease, partnership, pet health, veterinary innovation
(IN BRIEF) TUM and TUM University Hospital have been awarded $1.5 million by Google.org to create AIdvice, an AI-powered chatbot that provides cancer patients and medical professionals with reliable, personalized information. Built around a bespoke guidelines database, AIdvice will use … Read the full press release
Posted in Artificial Intelligence (AI), Business, Education, Environment, Financial, Germany, Healthcare, Industrial, Internet & Online, Investment, Management, Marketing, News, Science, Technology
Tagged AI hallucinations, AIdvice, cancer information, clinical pilot, data protection, Dr Jan Peeken, evidence-based answers, Florian Matthes, Google.org Accelerator: Generative AI, knowledge database, Large Language Model, Munich Data Science Institute, partnership, Radiation Oncology and Radiotherapy, source attribution, sustainability, Technical University of Munich, TUM University Hospital
(IN BRIEF) EQT Life Sciences has led a Series A investment in Mosanna Therapeutics to advance its lead drug candidate, MOS118—a nasal spray designed to treat obstructive sleep apnea—into Phase 2 trials. Co-investors include Pivotal bioVenture Partners, Forbion, Norwest, and … Read the full press release
Posted in Business, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Sweden, Switzerland, Technology
Tagged airway reflex restoration, Basel, biotech funding, Daniela Begolo, David Weber, EQT Life Sciences, Forbion, Forty51 Ventures, HTGF, MOS118, Mosanna Therapeutics, nasal spray therapy, neurological treatment, non-invasive sleep apnea therapy, Norwest, obstructive sleep apnea, OSA treatment, partnership, Phase 2 clinical trial, Pivotal bioVenture Partners, Redwood City, Supermoon Capital, sustainability
(IN BRIEF) Wolters Kluwer Health has announced comprehensive updates to its Sentri7 Drug Diversion and Sentri7 Pharmacy solutions, enhancing medication safety and compliance workflows for healthcare teams. The upgraded tools feature more intuitive user interfaces, improved risk scoring, enhanced documentation, … Read the full press release
Posted in Artificial Intelligence (AI), Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, Netherlands, News, Technology
Tagged artificial intelligence in healthcare, clinical workflows, cost savings, digital health, Drug Diversion, healthcare compliance, Healthcare Innovation, HEAT score, hospital pharmacy tools, Karen Kobelski, KLAS Research, medication management, medication safety, nursing workflows, opioid crisis, patient safety, pharmacy surveillance, risk management, Sentri7, Sentri7 Pharmacy, Wolters Kluwer
(IN BRIEF) Sanofi has launched early global shipments of Beyfortus (nirsevimab) in anticipation of the 2025–2026 RSV season, enabling healthcare providers to begin immunizations well before the typical onset of infections in November. In collaboration with AstraZeneca, Sanofi has significantly … Read the full press release
Posted in Business, Financial, France, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged AstraZeneca, Beyfortus, EU label, extended protection, global distribution, hospitalizations, infant immunization, lower respiratory tract disease, monoclonal antibody, newborn care, nirsevimab, pediatric health, public health, real-world studies, respiratory syncytial virus, RSV, RSV season, Sanofi, Thomas Triomphe, Vaccine Innovation, vaccine supply chain
(IN BRIEF) At the 10th Open Meeting of the Spanish Network of Healthy Companies, Sener was recognized for its Sener Care programme and commitment to promoting workplace health. The award highlights Sener’s comprehensive health initiatives, including disease prevention, psychological support, … Read the full press release
Posted in Awards, Business, Financial, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, Marketing, Media, News, Spain, Technology
Tagged ADIF, Awards, Castilla-La Mancha, corporate health, disease prevention, Employee Wellbeing, health initiatives, healthy lifestyle habits, HSE, INSST, leadership, psychological support, Renfe, Sacyr, SENER, Sener Care, Spanish Heart Foundation, Spanish Network of Healthy Companies, workplace health, workplace safety
(IN BRIEF) AstraZeneca’s Calquence, in combination with venetoclax, with or without obinutuzumab, has been approved by the European Commission for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (CLL). The approval follows the positive results from the … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged AMPLIFY Phase III trial, AstraZeneca, Barbara Eichhorst, BTK inhibitor, Calquence, chemoimmunotherapy, chronic lymphocytic leukaemia, clinical trial, CLL, Dave Fredrickson, European Commission approval, European Union, fixed-duration regimen, hematologic diseases, hematology, leukemia, obinutuzumab, oncology, progression-free survival, treatment option, venetoclax
(IN BRIEF) Dr. Steffen Knoblauch from Heidelberg University has developed a high-resolution environmental suitability map for the Aedes aegypti mosquito in Rio de Janeiro, using geospatial big data such as satellite imagery and climate data. The map, which models 79 … Read the full press release
Posted in Business, Education, Environment, Financial, Germany, Healthcare, Industrial, Investment, Management, News, Science, Technology
Tagged Aedes aegypti, Austrian Science Fund, Brazil, chikungunya, climate data, Dengue, Dr. Steffen Knoblauch, environmental suitability map, GeoAI, Geospatial Artificial Intelligence, geospatial big data, German Research Foundation, Heidelberg University, HeiGIT, infectious diseases, IWR, mosquito breeding sites, Rio de Janeiro, satellite imagery, spatio-temporal modeling, The Lancet Planetary Health, urban heat island, urbanization, vector control, yellow fever, ZIKA
(IN BRIEF) SCHOTT Pharma has begun construction on a new production facility for ready-to-use (RTU) cartridges at its Lukácsháza site in Hungary. The investment of over 100 million euros will expand the company’s manufacturing capacity to meet increasing demand for … Read the full press release
Posted in Business, Environment, Financial, Germany, Government, Healthcare, Hungary, Industrial, Infrastructure & Utilities, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged Andreas Reisse, biologics, Diabetes, Eva Szabó, expansion, GLP-1 drugs, high-value solutions, hormone therapies, Hungary, insulin, investment, Lukácsháza, manufacturing capacity, Ministry of Foreign Affairs and Trade, Obesity, partnership, pharmaceutical industry, pharmaceutical packaging, ready-to-use cartridges, SCHOTT Pharma, sterile cartridges, sustainability, sustainable development
(IN BRIEF) Fresenius Medical Care has received FDA 510(k) clearance for its updated 5008X CAREsystem with additional features, enabling the introduction of high-volume hemodiafiltration therapy across the U.S. This new therapy, proven to reduce mortality rates by 23% in patients, … Read the full press release
Posted in Business, Environment, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Security & Safety, Technology
Tagged 5008X CAREsystem, CDX™, Clinical Data Exchange, CONVINCE study, FDA 510(k) clearance, Fresenius Kidney Care, Fresenius Medical Care, FX CorAL dialyzer, hemodialysis, high-volume hemodiafiltration, INNOVATION, kidney care, kidney disease treatment, mortality reduction, partnership, patient care, renal disease, U.S. rollout
(IN BRIEF) The Viessmann Foundation has donated €5.6 million to the German Cancer Research Center (DKFZ) to advance research into cancer prevention through nutrition and the development of new treatments for pediatric oncology. This five-year funding will support vital research … Read the full press release
Posted in Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Non Profit, Science, Technology
Tagged Cancer Prevention, cancer research, Cancer Therapies, DKFZ, donation, Fostering Future Generations, Healthcare, Max Viessmann, Michael Baumann, Nutrition, pediatric cancer treatments, pediatric oncology, Viessmann Foundation, Viessmann Generations Group
(IN BRIEF) SGS has acquired H2Safety, a leading Canadian provider of emergency management and operational safety solutions, to bolster its Health & Safety offering in North America. This acquisition expands SGS’s capabilities in key areas such as emergency management, business … Read the full press release
Posted in Business, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Security & Safety, Switzerland, Technology
Tagged acquisition, Business Continuity, certification, emergency management, H2Safety, Health & Safety, infrastructure protection, inspection, North America, operational safety, partnership, regulatory compliance, risk mitigation, safety services, SGS, sustainability, testing
(IN BRIEF) Roche announced the European Commission’s approval of a label extension for Evrysdi® (risdiplam) to include a new 5mg tablet, offering a room-temperature stable alternative to the original oral solution for individuals with spinal muscular atrophy (SMA). The tablet, … Read the full press release
Posted in Healthcare, Pharma & Biotech, Science, Switzerland, Technology
Tagged 5mg tablet, bioequivalence, clinical development, clinical study, disease-modifying treatment, European Commission, Evrysdi, family caregivers, label extension, Nicole Gusset, non-invasive treatment, PTC Therapeutics, risdiplam, Roche, SMA, SMA Europe, SMA Foundation, SMA patients, SMN protein, spinal muscular atrophy, treatment flexibility
(IN BRIEF) The European Investment Bank (EIB) has signed a €20 million financing deal with Leyden Laboratories to support the development of its innovative pan-influenza nasal spray, which aims to protect against seasonal and pandemic viral infections. The funding, guaranteed … Read the full press release
Posted in Banks, Business, Economy, Environment, Financial, Government, Healthcare, Industrial, Investment, Luxembourg, Management, Marketing, Netherlands, News, Pharma & Biotech, Science, Technology
Tagged antiviral protection, avian flu, biodefense, EU4Health, European Commission, European health defense, European Investment Bank, Hadja Lahbib, HERA Invest, influenza, InvestEU, Koenraad Wiedhaup, Leyden Labs, nasal spray, non-vaccine approach, Pandemic Preparedness, partnership, respiratory viruses, Robert de Groot, sustainability
(IN BRIEF) Rilzabrutinib, an oral Bruton’s tyrosine kinase (BTK) inhibitor, has received orphan drug designation from the U.S. FDA for sickle cell disease. This marks the fourth such designation for the drug, which has already been recognized for its potential … Read the full press release
Posted in Business, Financial, France, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged BTK inhibitor, fast track status, FDA, IgG4-related disease, immune thrombocytopenia, multi-immune modulation, orphan drug designation, preclinical data, rare diseases, rilzabrutinib, Sanofi, sickle cell disease, Tailored Covalency®, vaso-occlusive crises, warm autoimmune hemolytic anemia
(IN BRIEF) A study by the University of Helsinki has uncovered why some breast cancer treatments, including immunotherapy, may not be effective for all patients. The research, focusing on the mechanical properties of tumor tissue, shows that softer tissue environments … Read the full press release
Posted in Business, Education, Financial, Finland, Healthcare, Industrial, Investment, Management, News, Science, Technology
Tagged breast cancer, cancer research, cancer treatment, Finland, global research collaboration, HUS Helsinki University Hospital, immunotherapy, Kymenlaakso Health, MD-PhD student Aino Peura, Nature Communications, personalized medicine, tissue microenvironment, tumor progression, University of Helsinki
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?